Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment

por Vendrell, Julie A., Quantin, Xavier, Serre, Isabelle, Solassol, Jérôme
Publicado 2020

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

por Cohen, Pascale A., Donini, Caterina F., Nguyen, Nhan T., Lincet, Hubert, Vendrell, Julie A.
Publicado 2015

EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome

por Vendrell, Julie A., Quantin, Xavier, Aussel, Audrey, Solassol, Isabelle, Serre, Isabelle, Solassol, Jérôme
Publicado 2021

Determination of the Optimal Bacterial DNA Extraction Method to Explore the Urinary Microbiota

por Vendrell, Julie A., Henry, Steven, Cabello-Aguilar, Simon, Heckendorn, Elise, Godreuil, Sylvain, Solassol, Jérôme
Publicado 2022

Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management

por Vendrell, Julie A., Mau-Them, Frédéric Tran, Béganton, Benoît, Godreuil, Sylvain, Coopman, Peter, Solassol, Jérôme
Publicado 2017

MRP8/ABCC11 Expression Is Regulated by Dexamethasone in Breast Cancer Cells and Is Associated to Progesterone Receptor Status in Breast Tumors

por Honorat, Mylène, Mesnier, Aurélia, Vendrell, Julie, Di Pietro, Attilio, Lin, Valérie, Dumontet, Charles, Cohen, Pascale, Payen, Léa
Publicado 2011

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens

por Frouin, Eric, Maudelonde, Thierry, Senal, Romain, Larrieux, Marion, Costes, Valérie, Godreuil, Sylvain, Vendrell, Julie A., Solassol, Jérôme
Publicado 2016

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma

por Blateau, Pauline, Coyaud, Etienne, Laurent, Estelle, Béganton, Benoit, Ducros, Vincent, Chauchard, Géraldine, Vendrell, Julie A., Solassol, Jérôme
Publicado 2020

ifCNV: A novel isolation-forest-based package to detect copy-number variations from various targeted NGS datasets

por Cabello-Aguilar, Simon, Vendrell, Julie A., Van Goethem, Charles, Brousse, Mehdi, Gozé, Catherine, Frantz, Laurent, Solassol, Jérôme
Publicado 2022

Case report: Liquid biopsy, the sooner the better?

por Thomas, Quentin Dominique, Colard-Thomas, Julien, Delansay, Delphine, Leenhardt, Fanny, Solassol, Jerome, Vendrell, Julie A., Quantin, Xavier
Publicado 2022

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

por Vilquin, Paul, Donini, Caterina F, Villedieu, Marie, Grisard, Evelyne, Corbo, Laura, Bachelot, Thomas, Vendrell, Julie A, Cohen, Pascale A
Publicado 2015

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications

por Nugoli, Mélanie, Chuchana, Paul, Vendrell, Julie, Orsetti, Béatrice, Ursule, Lisa, Nguyen, Catherine, Birnbaum, Daniel, Douzery, Emmanuel JP, Cohen, Pascale, Theillet, Charles
Publicado 2003

High-throughput detection of clinically targetable alterations using next-generation sequencing

por Vendrell, Julie A., Grand, David, Rouquette, Isabelle, Costes, Valérie, Icher, Samira, Selves, Janick, Larrieux, Marion, Barbe, Aurore, Brousset, Pierre, Solassol, Jérôme
Publicado 2017

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

por Poulard, Coralie, Jacquemetton, Julien, Trédan, Olivier, Cohen, Pascale A., Vendrell, Julie, Ghayad, Sandra E., Treilleux, Isabelle, Marangoni, Elisabetta, Le Romancer, Muriel
Publicado 2019

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer

por Bellanger, Aurélie, Le, Diep T., Vendrell, Julie, Wierinckx, Anne, Pongor, Lőrinc S., Solassol, Jérôme, Lachuer, Joël, Clezardin, Philippe, Győrffy, Balázs, Cohen, Pascale A.
Publicado 2021

ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

por Thollet, Aurélie, Vendrell, Julie A, Payen, Léa, Ghayad, Sandra E, Ben Larbi, Sabrina, Grisard, Evelyne, Collins, Colin, Villedieu, Marie, Cohen, Pascale A
Publicado 2010

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer

por Vendrell, Julie A., Solassol, Jérôme, Győrffy, Balázs, Vilquin, Paul, Jarlier, Marta, Donini, Caterina F., Gamba, Laurent, Maudelonde, Thierry, Rouanet, Philippe, Cohen, Pascale A.
Publicado 2019

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer

por Vendrell, Julie A., Ban, Iulian O., Solassol, Isabelle, Audran, Patricia, Cabello-Aguilar, Simon, Topart, Delphine, Lindet-Bourgeois, Clothilde, Colombo, Pierre-Emmanuel, Legouffe, Eric, D’Hondt, Véronique, Fabbro, Michel, Solassol, Jérôme
Publicado 2023

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

por Vendrell, Julie A, Robertson, Katherine E, Ravel, Patrice, Bray, Susan E, Bajard, Agathe, Purdie, Colin A, Nguyen, Catherine, Hadad, Sirwan M, Bieche, Ivan, Chabaud, Sylvie, Bachelot, Thomas, Thompson, Alastair M, Cohen, Pascale A
Publicado 2008

Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer

por Fabbro, Michel, Colombo, Pierre-Emmanuel, Leaha, Cristina Marinella, Rouanet, Philippe, Carrère, Sébastien, Quenet, François, Gutowski, Marian, Mourregot, Anne, D’Hondt, Véronique, Coupier, Isabelle, Vendrell, Julie, Vilquin, Paul, Pujol, Pascal, Solassol, Jérôme, Mollevi, Caroline
Publicado 2020